Natural heat shock protein 90 inhibitors in cancer and inflammation
- PMID: 31972392
- DOI: 10.1016/j.ejmech.2020.112063
Natural heat shock protein 90 inhibitors in cancer and inflammation
Abstract
Heat shock protein (HSP)90 is the most abundant HSPs, which are chaperone molecules whose major roles are cell protection and maintenance by means of aiding the folding, the stabilization and the remodeling of a wide range of proteins. A few hundreds of proteins depend on HSP90 chaperone activity, including kinases and transcriptional factors that play essential roles in cancer and inflammation, so that HSP90-targeted therapies have been considered as a potential strategy for the treatment of cancer and inflammatory-associated diseases. HSP90 inhibition by natural, semi-synthetic and synthetic compounds have yield promising results in pre-clinical studies and clinical trials for different types of cancers and inflammation. Natural products are a huge source of biologically active compounds widely used in drug development due to the great diversity of their metabolites which are capable to modulate several protein functions. HSP90 inhibitors have been isolated from bacteria, fungi and vegetal species. These natural compounds have a noteworthy ability to modulate HSP90 activity as well as serve as scaffolds for the development of novel synthetic or semi-synthetic inhibitors. Over a hundred clinical trials have evaluated the effect of HSP90 inhibitors as adjuvant treatment against different types of tumors and, currently, new studies are being developed to gain sight on novel promising and more effective approaches for cancer treatment. In this review, we present the naturally occurring HSP90 inhibitors and analogues, discussing their anti-cancer and anti-inflammatory effects.
Keywords: Cancer; HSP90; Inflammation; Natural products.
Copyright © 2020. Published by Elsevier Masson SAS.
Conflict of interest statement
Declaration of competing interest The authors declare to have no conflict of interest.
Similar articles
-
Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.Cancer Res. 2006 Feb 1;66(3):1783-91. doi: 10.1158/0008-5472.CAN-05-3692. Cancer Res. 2006. PMID: 16452239
-
Small molecule inhibitors targeting heat shock protein 90: An updated review.Eur J Med Chem. 2024 Sep 5;275:116562. doi: 10.1016/j.ejmech.2024.116562. Epub 2024 Jun 3. Eur J Med Chem. 2024. PMID: 38865742 Review.
-
Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies.Comput Biol Chem. 2019 Dec;83:107113. doi: 10.1016/j.compbiolchem.2019.107113. Epub 2019 Sep 5. Comput Biol Chem. 2019. PMID: 31493740
-
Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects.Adv Cancer Res. 2016;129:51-88. doi: 10.1016/bs.acr.2015.12.001. Epub 2016 Feb 10. Adv Cancer Res. 2016. PMID: 26916001 Free PMC article. Review.
-
HSP90 and its inhibitors.Oncol Rep. 2010 Jun;23(6):1483-92. doi: 10.3892/or_00000787. Oncol Rep. 2010. PMID: 20428801 Review.
Cited by
-
The Liver-Protective Effects of the Essential Oil from Amomum villosum in Tilapia (Oreochromis niloticus): Antioxidant, Transcriptomic, and Metabolomic Modulations.Antioxidants (Basel). 2024 Sep 16;13(9):1118. doi: 10.3390/antiox13091118. Antioxidants (Basel). 2024. PMID: 39334777 Free PMC article.
-
Alkaloid Derivative (Z)-3β-Ethylamino-Pregn-17(20)-en Inhibits Triple-Negative Breast Cancer Metastasis and Angiogenesis by Targeting HSP90α.Molecules. 2022 Oct 21;27(20):7132. doi: 10.3390/molecules27207132. Molecules. 2022. PMID: 36296726 Free PMC article.
-
Anti-inflammatory activities of novel heat shock protein 90 isoform selective inhibitors in BV-2 microglial cells.Front Mol Biosci. 2024 May 2;11:1405339. doi: 10.3389/fmolb.2024.1405339. eCollection 2024. Front Mol Biosci. 2024. PMID: 38756532 Free PMC article.
-
HSP90, a Common Therapeutic Target for Suppressing Skin Injury Caused by Exposure to Chemically Diverse Classes of Blistering Agents.J Pharmacol Exp Ther. 2024 Jan 17;388(2):546-559. doi: 10.1124/jpet.123.001795. J Pharmacol Exp Ther. 2024. PMID: 37914412 Free PMC article.
-
Plant-Based HSP90 Inhibitors in Breast Cancer Models: A Systematic Review.Int J Mol Sci. 2024 May 17;25(10):5468. doi: 10.3390/ijms25105468. Int J Mol Sci. 2024. PMID: 38791506 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Medical